Excellence through Research and Development of Innovative Biotechnology

HA TECH is an Australian based Company, Developing & Delivering innovative Diagnostic and Pharmaceuticals products, focuses on the diagnosis of serious infectious diseases: respiratory Including COVID-19, sexually transmitted infection (STI) and mosquito-borne diseases that affect hundreds of millions of people worldwide and are among the most urgent global health challenges. The Company is making long-term investments to develop pharmaceutical products and medical technologies/ devices to address major health problem in Australia and globally.

HA TECH is looking to change the industry status quo.

As members of the global healthcare community, HA TECH focuses on reducing the burden of disease with our products and development of novel technologies.
HA TECH aims to be inclusive and make diagnostic products that are accessible and only require basic laboratory equipment rather than restricting the use of kits to own brand equipment.
We value Science with our company run with an emphasis on researchers leading development.

Abdullah Mahmud

Executive Chairman

Read bio

Dr. Hani Nur

Managing Director
PhD (University of Greenwich, UK)

Read bio

Professor Martin Snowden

PhD, CSci, CChem, FRSC, PFHEA (UK)

Read bio

Professor Fariba Dehghani

PhD (University of New South Wales, Australia)

Read bio

Dr Peter Valtchev

PhD (University of Sydney, Australia)

Read bio

Ross William Brierty 

International Marketing Executive
B.Sc. MBA (Victoria University)

Read bio

Dr Mike Richardson

PhD (ANU, Australia)

Read bio

Prof. Shariff Enamul Kabir

PhD (University College London, UK)

Read bio